Quarterly report pursuant to Section 13 or 15(d)

Equity (Details) - Schedule of company???s nonvested stock options granted

v3.21.2
Equity (Details) - Schedule of company’s nonvested stock options granted
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Number of Options  
Equity (Details) - Schedule of company’s nonvested stock options granted [Line Items]  
Nonvested at beginning balance | shares 218,334
Number of Options Granted | shares 660,000
Number of Options Vested | shares (651,668)
Nonvested at ending balance | shares 226,666
Weighted Average Exercise Price  
Equity (Details) - Schedule of company’s nonvested stock options granted [Line Items]  
Nonvested at beginning balance | $ / shares $ 1.18
Weighted Average Exercise Price Granted | $ / shares 1.1
Weighted Average Exercise Price Vested | $ / shares (1.13)
Nonvested at ending balance | $ / shares $ 1.09